Vir Historical Cash Flow
| VIR Stock | USD 6.67 0.08 1.21% |
Analysis of Vir Biotechnology cash flow over time is an excellent tool to project Vir Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Sale Purchase Of Stock of 3.5 M or Change To Inventory of 63.8 M as it is a great indicator of Vir Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Vir Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vir Biotechnology is a good buy for the upcoming year.
Vir |
About Vir Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Vir balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vir's non-liquid assets can be easily converted into cash.
Vir Biotechnology Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Vir Biotechnology to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Vir Biotechnology operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Vir Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vir Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vir Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Vir Stock, please use our How to Invest in Vir Biotechnology guide.At this time, Vir Biotechnology's Investments are relatively stable compared to the past year. As of 03/28/2025, Begin Period Cash Flow is likely to grow to about 320.3 M, while Change In Cash is likely to drop slightly above 30.5 M.
Vir Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
Vir Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vir Biotechnology cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | (3K) | 327.3M | 15.4M | 3.2M | 3.7M | 3.5M | |
| Investments | (3.5M) | (119.0M) | (1.2B) | 116.3M | 499.4M | 524.3M | |
| Change In Cash | 328.7M | (88.1M) | 504.6M | (606.7M) | 57.4M | 30.5M | |
| Stock Based Compensation | 27.6M | 83.8M | 102.1M | 111.3M | 78.5M | 58.0M | |
| Free Cash Flow | (197.5M) | (69.4M) | 1.6B | (800.4M) | (453.7M) | (431.0M) | |
| Change In Working Capital | 29.5M | (628.4M) | 665.4M | (304.6M) | (84.0M) | (79.8M) | |
| Begin Period Cash Flow | 122.8M | 451.5M | 363.4M | 868.0M | 261.3M | 320.3M | |
| Total Cashflows From Investing Activities | (256.2M) | (9.9M) | (140.8M) | (1.2B) | (1.1B) | (1.0B) | |
| Other Cashflows From Financing Activities | (189K) | 15.4M | 6.6M | 7.8M | 4.4M | 4.2M | |
| Depreciation | 5.4M | 5.8M | 6.8M | 19.5M | 20.0M | 21.0M | |
| Other Non Cash Items | 45.2M | (52.6M) | 388.4M | 11.2M | (19.9M) | (18.9M) | |
| Capital Expenditures | 6.5M | 21.8M | 68.0M | 21.6M | 7.3M | 6.9M | |
| Total Cash From Operating Activities | (190.9M) | (47.6M) | 1.7B | (778.8M) | (446.4M) | (424.0M) | |
| Change To Operating Activities | 3.7M | 37.4M | (720.3M) | (72.2M) | (65.0M) | (68.2M) | |
| Net Income | (298.7M) | 528.6M | 515.8M | (615.1M) | (522.0M) | (495.9M) | |
| Total Cash From Financing Activities | 529.5M | 100.3M | 34.8M | 7.5M | 4.4M | 4.2M | |
| End Period Cash Flow | 451.5M | 363.4M | 868.0M | 261.3M | 318.7M | 362.2M | |
| Change To Netincome | 32.3M | 45.2M | 46.4M | 475.3M | 546.6M | 573.9M | |
| Change To Liabilities | 4.5M | 38.8M | 91.9M | (32.5M) | (37.4M) | (35.5M) |
Pair Trading with Vir Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vir Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Vir Stock
The ability to find closely correlated positions to Vir Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vir Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vir Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vir Biotechnology to buy it.
The correlation of Vir Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vir Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vir Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vir Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.